ʻAkika Madecassic me CAS 18449-41-7
ʻO ka waikawa Madecassic kahi triterpenoid i loaʻa ma C. asiatica a he mau hana olaola like ʻole. Hoʻopaʻa ia i ka hana ʻana o ka LPS i hoʻoulu ʻia e ka nitric oxide (NO), prostaglandin E2 (PGE2; Item No. 14010), TNF-α, IL-1β, a me IL-6 i loko o nā macrophages RAW 264.7 i ka wā e hoʻohana ʻia ai ma kahi nui o 150 μg/ml. Hoʻemi ka waikawa Madecassic (0.05 a me 0.1% i ka meaʻai) i nā pae plasma o ka fibrinogenin a me nā triglycerides, a me nā pae o ka puʻuwai a me nā puʻupaʻa o nā ʻano oxygen reactive (ROS), i loko o kahi kumu hoʻohālike ʻiole o ka maʻi diabetes i hoʻoulu ʻia e streptozotocin (STZ; Item No. 13104). Hoʻemi ia i ka ulu ʻana o ka puʻupuʻu i loko o kahi kumu hoʻohālike kanesa colon CT26 murine ma ke ʻano hilinaʻi i ka lāʻau.
| CAS | 18449-41-7 |
| Nā inoa | ʻAkika Madecassic |
| helehelena | Pauka |
| Maʻemaʻe | 98% |
| MF | C30H48O6 |
| Papa | Meaʻai $ Papa Lapaʻau |
| Pūʻolo | 25kgs/ʻeke, 20tons/20'pahu |
| Inoa Lama | ʻUnilong |
He terpenoid ka Madecassic Acid me kahi iwi ursane i hoʻokaʻawale ʻia mai Centella asiatica. Hōʻike ka Madecassic Acid i nā waiwai anti-inflammatory ma muli o ka iNOS, COX-2, TNF-alpha, IL-1beta, a me ka IL-6 inhibition ma o ka downregulation o ka hoʻāla ʻana o NF-kappaB i nā cell macrophage RAW 264.7.
25kgs/pahu, 9tons/20'pahu
25kgs/ʻeke, 20tons/20'pahu
ʻodium-dodecylbenzenesulphonate
